ACTU · Actuate Therapeutics, Inc.
$1.18
-0.08 (-6.35%)
At close · Jul 24
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the above matters, we have concluded that there is substantial doubt regarding the Company's ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$28.23M
Shares
23.93M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
Key facts
CIK
1652935
CUSIP
005083100
13F (30d)
12 filings
12 filers
Visit website
Investor relations